Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
27 studies found for:    " February 21, 2007":" March 23, 2007"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Download search resultsDownload the search results for:
" February 21, 2007":" March 23, 2007"[FIRST-RECEIVED-DATE]AND HIV[CONDITION] (27 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Completed Study To Evaluate Long Term Maintenance With TRIZIVIR After Boosted Protease Inhibitor (PI) Or Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) In HIV-1 Infected Adults
Condition: HIV Infections
Interventions: Drug: TRIZIVIR;   Drug: Non-nucleoside reverse transcriptase inhibitor;   Drug: Boosted Protease Inhibitor
2 Completed Multicenter Trial of Immunologic Markers to Predict Long Term Virologic Outcomes
Condition: HIV Infections
Intervention:
3 Completed Safety Study of UC-781 Vaginal Microbicide
Condition: HIV Infections
Interventions: Drug: Placebo gel;   Drug: UC 781
4 Completed Prospective Epidemiological Study Of The Prevalence Of HLAB*5701 In HIV-1 Infected Patients
Condition: HIV Infection
Intervention:
5 Completed Phase I Study of Safety and Persistence of UC-781 Vaginal Microbicide
Condition: HIV Infections
Interventions: Drug: UC-781;   Drug: UC-781 placebo
6 Completed Trial of Zinc and HIV Progression in Children
Condition: HIV Infections
Intervention: Dietary Supplement: Zinc
7 Terminated
Has Results
MK0518 in the Treatment of HIV-Infected Patients Switched From a Protease Inhibitor Regimen (0518-033)(TERMINATED)
Condition: HIV Infection
Interventions: Drug: Comparator: raltegravir;   Drug: Comparator: placebo;   Drug: Comparator: lopinavir (+) ritonavir
8 Terminated
Has Results
MK0518 in the Treatment of HIV-Infected Patients Switched From a Protease Inhibitor Regimen (0518-032)(TERMINATED)
Condition: HIV Infection
Interventions: Drug: MK0518 (raltegravir);   Drug: Comparator: KALETRA™ (lopinavir (+) ritonavir );   Drug: Comparator: placebo
9 Terminated
Has Results
Safety and Antiviral Activity of TPV in HCV and/or HBV HIV Coinfected Patients TDM Randomised Pilot Evaluation
Condition: HIV Infections
Interventions: Drug: tipranavir;   Drug: ritonavir
10 Completed
Has Results
HIV Treatment Reinitiation in Women Who Received Anti-HIV Drugs to Prevent Mother-to-Child Transmission of HIV
Condition: HIV Infections
Interventions: Drug: Efavirenz;   Drug: Emtricitabine/Tenofovir disoproxil fumarate
11 Terminated
Has Results
SPRING: Safety, Efficacy, Pharmacokinetics of tipRanavir/r IN Race/Gender HIV+ Patients Randomized to TDM or SoC
Condition: HIV Infections
Interventions: Drug: tipranavir;   Drug: ritonavir;   Drug: Optimized Background Regimen (OBR)
12 Completed
Has Results
Safety of EVG+RTV Administered With Other Antiretroviral Agents for the Treatment of HIV-1 Infection
Condition: HIV Infections
Interventions: Drug: EVG;   Drug: RTV;   Drug: ARV regimen
13 Completed Botswana TDF/FTC Oral HIV Prophylaxis Trial
Condition: HIV Infections
Interventions: Drug: Tenofovir Disoproxil Fumarate 300 mg + Emtricitabine 200 mg;   Drug: TDF-FTC placebo
14 Completed Safety and Effectiveness Study of a Candidate Vaginal Microbicide for Prevention of HIV
Condition: HIV Infections
Interventions: Drug: Tenofovir gel;   Drug: Placebo (Universal HEC placebo)
15 Completed Computer Assisted Rx Education for HIV-Positives: CARE+
Conditions: HIV Infections;   Acquired Immunodeficiency Syndrome
Intervention: Behavioral: CARE+
16 Completed Positive Choice: Prevention for Positive Health
Conditions: HIV Infections;   Sexual Risk Behavior;   Substance Use Risks
Intervention: Behavioral: Positive Choice
17 Completed Project Hope: Hospital Visit is an Opportunity for Prevention and Engagement With HIV-positive Crack Users
Conditions: HIV Infections;   Crack Cocaine Use;   Risky Sexual Behavior
Intervention: Behavioral: Prevention Care Advocate
18 Completed Effect of Atazanavir on Endothelial Function in HIV-Infected Patients
Conditions: HIV Infections;   Dyslipidemia
Intervention: Drug: ATAZANAVIR
19 Completed HIV Prevention Among Substance Abusing SMI
Conditions: Mentally Ill Persons;   Substance Abuse;   HIV Infections
Intervention: Behavioral: PATH
20 Completed Enhancing Oral Health Care Use by HIV Positive Individuals
Conditions: Oral Health Care;   HIV Infections;   Mouth Diseases
Intervention: Behavioral: Case-management linkage intervention

   Previous Page Studies Shown (1-20) Next Page (21-27) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.